Hemostatic Agents Market by IndustryARC

Hemostatic Agents Market By Materials, By Product, By Preparation Method, By Application and By Geography Analysis - Forecast 2019 - 2024 www.industryarc.com

Hemostatic Agents Market 2019-2024

sales@industryarc.com

Industry Market Research for Business Leaders, Strategists, Decision Makers

Press Release

Despite the introduction of minimally invasive surgical techniques, invasive procedures still remain a prevalent mode of surgical treatments worldwide. Such procedures require hemostasis, which facilitates the first step in healing wounds, thus resulting in a high demand for the hemostatic agents market, according to a market intelligence report by IndustryARC. Moreover, internal and external bleeding are common occurrences amongst patients who have undergone surgeries or accidents, which further elevates demand for hemostatic agents in hospitals and clinics. According to the report, the hemostatic agents market will earn revenue amounting to $8,347.9m by the end of 2022, after growing at a CAGR of 7.1% during the forecast period of 2019-2024. The report titled, ‘Hemostatic Agents Market: By Type (Thrombin, Oxidized Regenerated Cellulose, Combination, Gelatin, Collagen, Fibrin Sealants); By Treatment (Cardiovascular, General, Digestive, Neurological); By End User (Hospitals, Surgical Centers, Nursing Homes) & Geography - Forecast (2019-2024)’, delves into various market forces in order to explain in detail this market’s opportunities such as declining prices of hemostatic agents in the APAC region, increased usage of hemostasis in dentistry, and others. The leading segment of the market is estimated to be hospitals, which will grow at a CAGR of 8.1% through to 2025. Hemostatic Agents Market: Regional Analysis According to the report, around 80% Americans suffer from spinal issues and regularly consult hospitals for spinal surgical operations. As a result, the requirement for hemostatic agents is high in the U.S.A. in order to control bleeding during orthopaedic, spinal, and similar surgical procedures. Transplant surgeries of vital organs such as the heart, brain, and liver, which are being performed at an elevated rate due to a steady rise in chronic illnesses, are another contributing factor for this market. Together, these factors have made North America the geographical leader of the global hemostatic agents market with a share of $3,416.7m in 2018. Hemostatic Agents Market: Market Opportunities And Trends ·

The APAC region’s share of the hemostatic agents market is growing at a potentially higher rate owing to emergence of hospital chains in India, China, South Korea, and Japan.

· Collagen-based hemostatic agents have become more popular in the current scenario owing to the growing expense of thrombin-based hemostats. · Rising aesthetic consciousness among people has resulted in a noticeable rise in dental consumables, which forms an important application segment for the hemostatic agents market, since hemostats are used to control dental haemorrhage and for wound protection. Hemostatic Agents Market: Competitive Landscape And Recent Developments

Hemostatic Agents Market

Key companies operating in the global hemostatic agents market are Baxter International Corporation, C.R. Bard Incorporation, B. Braun Melsungen AG, Integra Life Sciences Corporation, Equimedical B.V., Marine Polymer Technologies, Inc., Gelita GmbH, Johnson and Johnson Services Inc., Pfizer Inc., Advanced Medical Solutions Group, Vascular Solutions Inc., Z-Medica LLC, and Mallinckrodt PLC. Âˇ

Baxter International Corporation recently launched HDx enabled by Theranova Therapy to provide high-performance hemodialysis treatments.

Âˇ

C.R. Bard launched Arisa AH which is a 100% plant-based absorbable surgical hemostatic powder.

Talk to one of our sales representative about the full report by providing your details in the link below: https://industryarc.com/support.php?id=15189 Related Reports: Hemodynamic Monitoring Systems Market https://industryarc.com/Report/10602/hemodynamic-monitoring-system-market.html Varicose Vein Treatment Market https://industryarc.com/Report/17006/varicose-vein-treatment-market.html Blood Culture Tests Market https://industryarc.com/Report/10633/blood-culture-tests-market.html What can you expect from the report? The hemostatic agents market report is prepared with the main agenda to cover the following 20 points:

1. Market Size by Product Categories & Application (Revenue & 2. Market trends & Relevant Market Data

11. Demand Analysis Volume) 12. Country level Analysis

3. Manufacturer Landscape

13. Competitor Analysis

4. Distributor Landscape

14. Market Shares Analysis

5. Pricing Analysis

15. Value Chain Analysis

6. Top 10 End user Analysis

16. Supply Chain Analysis

7. Product Benchmarking

17. Strategic Analysis

8. Product Developments Landscape 9. Mergers & Acquisition Analysis 10. Patent Analysis Analysis

Hemostatic Agents Market

18. Current & Future Market Analysis 19. Opportunity Analysis 20. Revenue and Volume

Frequently Asked Questions: Q. Does IndustryARC provide customized reports and charge additionally for limited customization? Response: Yes, we can customize the report by extracting data from our database of reports and annual subscription databases. We can provide the following free customization: 1. Increase the level of data in application or end user industry. 2. Increase the number of countries in geography chapter. 3. Find out market shares for other smaller companies or companies which are of interest to you. 4. Company profiles can be requested based on your interest. 5. Patent analysis, pricing, product analysis, product benchmarking, value and supply chain analysis can be requested for a country or end use segment. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services. To request for a quote, provide your details in the below link: https://industryarc.com/reports/request-quote?id=15189 Media Contact: Mr. Venkat Reddy Sales Manager Email 1: sales@industryarc.com Or Email 2: venkat@industryarc.com Contact Sales: +1-614-588-8538 (Ext-101) About IndustryARC: IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life sciences and Healthcare.

Hemostatic Agents Market

Industry Market Research for Business Leaders, Strategists, Decision Makers

Table of Contents 1. Hemostatic Agents Market Overview 2. Hemostatic Agents Market Executive Summary 3. Hemostatic Agents Market Landscape 3.1. Market Share Analysis 3.2. Financial Analysis 3.3. End User Profiling 3.4. Product Benchmarking 3.5. Patent Analysis 4. Hemostatic Agents Market Forces 4.1. Market Drivers 4.2. Market Constraints & Challenges 4.3. Attractiveness of Hemostatic Agents Market 4.3.1. Power of Suppliers 4.3.2. Power of Buyers 4.3.3. Threat of Substitutes 4.3.4. Threat of New entrants 4.3.5. Degree of Competitive Rivalry 5. Hemostatic Agents Market– Strategic Analysis 5.1. Value Chain Analysis 5.2. Opportunities Analysis 5.3. Market Life Cycle Analysis 5.4. Pricing Analysis 6. Hemostatic Agents Market – By Type 6.1. Introduction 6.2. Thrombin Based Hemostats 6.3. Gelatin Based Hemostats 6.4. Collagen Based Hemostats 6.5. Oxidized Regenerated Cellulose Based Hemostats 6.6. Combination Hemostats 6.7. Fibrin Sealants 6.8. Others 7. Hemostatic Agents Market – By Treatment 7.1. Introduction 7.2. Cardiovascular 7.3. General Surgery 7.4. Digestive Surgery 7.5. Neurosurgery 7.6. Others 8. Hemostatic Agents Market – By End User 8.1. Introduction 8.2. Hospitals 8.3. Surgery Centers 8.4. Nursing Homes 8.5. Others 9. Hemostatic Agents Market -Geographic Analysis 9.1. Introduction 9.2. Americas 9.2.1. U.S 9.2.2. Canada

Hemostatic Agents Market

9.2.3. Mexico 9.2.4. Brazil 9.2.5. Rest of Americas 9.3. Europe 9.3.1. U.K. 9.3.2. Germany 9.3.3. France 9.3.4. Italy 9.3.5. Rest of Europe 9.4. Asia-Pacific 9.4.1. China 9.4.2. Japan 9.4.3. India 9.4.4. Australia & New Zealand 9.4.5. South Korea 9.4.6. Rest of APAC 9.5. RoW 9.5.1. Africa 9.5.2. Middle East 10. Hemostatic Agents Market Entropy 11. Hemostatic Agents Market Company Profiles 11.1. Baxter International Incorporation (U.S.) 11.2. C.R. Bard Incorporation (U.S.) 11.3. B.Braun Melsungen AG (Germany) 11.4. Integra Life Sciences Corporation (U.S.) 11.5. Equimedical (Netherlands) 11.6. Marine Polymer Technologies (U.S.) 11.7. Gelita GmbH (Germany) 11.8. Johnson and Johnson Services Inc (U.S.) 11.9. Pfizer Inc (U.S.) 11.10. Advanced Medical Solutions Group (U.K.) 11.11. Vascular Solutions, Inc (U.S.) 11.12. Z-Medica LLC (U.S.) 11.13. Mallinckrodt Plc (U.S.) *More than 10 Companies are profiled in this Research Report* "*Financials would be provided on a best efforts basis for private companies" 12. Appendix 12.1. Abbreviations 12.2. Sources 12.3. Research Methodology 12.4. Bibliography 12.5. Compilation of Expert Insights 12.6. Disclaimer

Hemostatic Agents Market

Industry Market Research for Business Leaders, Strategists, Decision Makers

IndustryARC Solutions We cater to the pain points of our clients by providing the following solutions, which are targeted and address key issues specifically. Each of the business verticals is helpful to a client at various stages of their operational, managerial and strategic level plans. Syndicate Reports and Consulting (SRC) 1. Provide high quality analytical syndicated reports with key market insights, strategies and market forecasts for a specific industry or vertical of the clients. Constant tracking of industries and relations with experts helps us to predict and publish reports before our competitors as well as meet client needs proactively. Market Research and Data Analytics (MRDA) 2. Provide pure play data analytics services for ad-hoc and long-term engagement projects of clients with market research layered into the analysis. We are the only global company to offer this combination one-stop service to clients. Redundancies generally seen by procuring data, analytics services from multiple vendors is overcome by our solution. Competitive Landscape Analysis (CLA) 3. Provide company financial analysis, market share analysis, competitive landscape insights and market movements to clients. This is one of the most important pain point and key request from majority of our clients, for which we use our proprietary methodologies to provide accurate CLA data. Accelerated Business Development (ABD) 4. Connect clients with their customers on a global scale by acting as an outsourced sales team on behalf of the client. This is a unique tri-party engagement model to benefit the client and their customer, and acts as a business development scale up at an international level. Market Intel Reports (MIR) 5. Provide one-stop venue with a searchable syndicate reports database from global companies available to clients. This augments our offerings exponentially and also assists in studying global client needs at an in-depth level.

Hemostatic Agents Market

Industry Market Research for Business Leaders, Strategists, Decision Makers

About IndustryARC IndustryARC strategy studies primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights on the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business. We look forward to support the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals.

We Work for You For IndustryARC, we value every customer equally. We only stay ready to help each client in the best way possible with a unique 24x365 support plan. We suggest looking at the following benefits of relying on Professional Business Consulting and Custom Market Research Services to realize the unique strategic gains on offer: 1. 2. 3. 4. 5. 6. 7.

Strengthen and improve organizational performance Strategic planning and analysing Adoption of newer and cost-effective technologies Become environmentally sustainable and profitable Improve their training and certification procedures. Planning for business automation. Project facilitation and management.

Hemostatic Agents Market